Discover Community Create You

Loading publication...

Noodle always counts identifier-free feature events for service operation. With your permission, Google Analytics can also estimate audience and engagement. Search text, publication identifiers, cookies, IP addresses and browser fingerprints are never included in Noodle's first-party event counters.

Privacy details

Article

Unraveling the Wide Spectrum of Melanoma Biomarkers

26 Jul 2021

Abstract excerpt

The use of biomarkers in medicine has become essential in clinical practice in order to help with diagnosis, prognostication and prediction of treatment response. Since Alexander Breslow's original report on "melanoma and prognostic values of thickness", providing the first biomarker for melanoma, many promising new biomarkers have followed. These include serum markers, such as lactate dehydrogenase and S100...

Read the complete abstract on PubMed

Topics

Share this publication in a Topic to start or enrich a Post.

Share to Computational Drug Discovery Methods
Share to Cutaneous Melanoma Detection and Management
Share to Melanoma and MAPK Pathways

Methodology Data sources Editorial policy Privacy About Contact Helena Bioinformatics

Source

Identifiers

PMID: 34441278
DOI: 10.3390/diagnostics11081341

Provenance

PubMed metadata and Literature Corpus relationships. Corpus snapshot updated 7 Sept 2026.

Related research

Semantic proximity does not establish scientific evidence.

Research trail→

Click a neighbor to travelStep 1 · 12 closest

Unraveling the Wide Spectrum of Melanoma BiomarkersPMID 34441278Read ↗

Prognostic and predictive biomarkers in melanoma: an updateSemantic proximity Read ↗

Prognostic biomarkers in melanoma: a 2023 update from clinical trials in different therapeutic scenarios.Semantic proximity Read ↗

Biomarkers in melanoma: predisposition, screening and diagnosis.Semantic proximity Read ↗

Melanoma pathology: new approaches and classification.Semantic proximity Read ↗

Melanoma subtypes: genomic profiles, prognostic molecular markers and therapeutic possibilitiesSemantic proximity Read ↗

Potential Biomarkers of Skin Melanoma Resistance to Targeted Therapy—Present State and PerspectivesSemantic proximity Read ↗

The Melanoma Pathology Report: What to Expect and How to Interpret ItSemantic proximity Read ↗

From Breslow to BRAF and immunotherapy: evolving concepts in melanoma pathogenesis and disease progression and their implications for changing management over the last 50 years.Semantic proximity Read ↗

Recognition, Staging, and Management of Melanoma.Semantic proximity Read ↗

Molecular Frontiers in Melanoma: Pathogenesis, Diagnosis, and Therapeutic Advances.Semantic proximity Read ↗

BRAF Mutations in Melanoma: Biological Aspects, Therapeutic Implications, and Circulating BiomarkersSemantic proximity Read ↗

Tumor Biomarkers in MelanomaSemantic proximity Read ↗

⌁Select a neighboring publication to make it the new centre.